||EPS - Basic
||Market Cap (m)
Brainjuicer Share Discussion Threads
Showing 451 to 475 of 475 messages
|Some of these have lovely charts
PVG BJU FARN WAND BOO
We've struck gold here
All those shares are 100% BUYS|
Another little beauty is BOO
It should make £2|
|WAND looks interesting wasn't aware of that one.|
£10 will only be 25% from now
I am following
PVG WAND FARN BJU for the long|
|Welcome essential.You are in at the start of a new era that should push BJU well above £10 over the next couple of years.Don't listen to me though: I am too emotionally involved.|
|Bought into these today. Stockopedia rank of 90+ and looking very strong technically|
|No worries.ODX is definitely the one I favour for short-term appreciation. A baillie Gifford fund manager has built up a personal stake of 11% - and I think it is good for a 50-100% share price rise over the next 6-12 months.The share at the bottom of my list: SPHR is a real basket case though and I certainly wouldn't buy just yet. Results announced today were awful.|
I like your IMM
Although other firms are also there (VEST?)
HUR also looks good
I couldn't get you video to work|
|Lets hope it all goes well
As a side issue
I bought an Android Tablet on Ebay (£50) and I use it every day
I have an App on it with four different portfolios that show
Share prices and charts daily and long term line and candle ones too
But for share chat ADVFN is best|
|With regard to the rebranding, I would recommend watching the video in the link I posted over the weekend.
I think the company know what they are doing. Having grown from a £15m outfit to a near £100m outfit, they want to reenergise the business for the next phase of growth that could well take them into the FTSE 250.
They have taken soundings from their largest investors who seem wholly supportive and whilst the process is not without its risks - their core client base is small and easy to manage so should be easy to align.
Overall I am excited about this next phase and the rebranding. If they can generate 30% CAGR each year for the next four years then this will become a very different company.
I also love the fact that they are doing the rebrand on April fool's day!
Regarding your purchase price: I would forget about it. You certainly haven't bought the shares cheap, but they are fair value. Better to have bought at £7.25 than >£8 as some have.
The company is throwing off cash, and without any acquisition targets in sight will be returning a lot of that cash to shareholders. If they achieve their growth targets organically, that rate of cash return is only going to accelerate.
You should look at holding shares over the long term and something like BJU/SYS1 with low liquidity and a trading spread of approx. 30p really discourages any short term trading activity.|
Thanks for that post
BJU is almost down to what I paid for it|
|Investing in shares can be a painful process; there are no magic formulae for success unfortunately.Avoid buying when the market is too hot (e.g. after news releases) and wait when share prices are dropping because they will probably drop further - are my two cardinal rules.I research my stocks carefully and tend to try and buy when no-one else is buying.No advice intended, but here is:Longshanks' bakers dozenIMM - immupharma ODX - Omega diagnosticsLTG - leaning technology groupSCE - surface TransformsVLE - volvereBJU - brainjuicer FARN - faron pharmaceuticalsNFC - next fifteen communicationsSOM - somero enterprisesHUR - hurricane energyRWS - RWS holdingsPTSG - premier technical servicesSPHR - sphere medical This is in my investing order of preference. IMM has astonishing potential. It is less than a year away from completing a phase 3 trial on a drug with blockbuster potential (>$1bn sales pa). Market is gradually waking up to that potential and you can still buy in cheap. It looks like a binary option on success of this drug, but the phase 2 data was so good it has been given the FDA special protocol assessment. The chances of success are far higher than for your typical drug trial.All the others are worth researching. I don't have stakes in them all - but they are all very much on my active watch list.|
|thanks for that common sense advice
sadly I am down on many aim shares where the chart did look good at first
do you think the rebranding will be in our favour?
any other shares in your portfolio which look good? that I can research ?|
|Yup and on the weekend the prices don't go up or down. Some investors are sad because they like to watch the prices move but others are happy because they have other things to do.|
|I worry saturn5 that your expectations from investing in stocks are a tad unrealistic.This is an AIM stock: one of higher quality than others, true, but still a constituent of a loosely regulated market and a highly illiquid stock at that.If you believe in "the story" that is great and if it works out, the price will appreciate over time as others buy the story too. However one cannot expect or demand the market to move in just an upward trajectory- that never happens.It is not "sad" for everyone that the price has dropped today. For those wanting to buy, it is a "happy" or "happier" day.By buying shares in a company, you have accepted the risk that you may lose money and you have done so for the chance to make a good long-term return. If you want security and constant value appreciation with your capital, stick to cash ISAs.|
sad to see it down today
|Nor I but to answer your question saturn5 - no, the share has not been suspended.|
|No idea what you are talking about Saturn5|
|Well the share price above is dead level|
|What makes you say that?|
|whats this all about
has the share price been suspended ?|
|whats this all about
has the share price been suspended ?|
|A video interview with John Kearon on the rebranding and what it all means.HTTPs://m.youtube.com/watch?time_continue=1829&ebc=ANyPxKrtjOhTv193A5B9HFn2qIV7KzdYaKQta-eBLND64BOGnYgpxGxT4iQlPPMut3helBfYi9is&v=9sOxZPq3h5k|
|I guess the point is that if they achieve profits of 185% above those of today's, then the share price will be much, much higher in 4 years time and we should be happy to have this level of dilution. A vesting threshold of 10% pa (46% over 4 years) seems reasonable.This is a "people business" and they need to retain the brightest and best.|
|Not generally a fan of such schemes at all, but the circular makes it clear that it has been devised in consultation with major shareholders and given the tiered nature of the plan and the ambitious higher-end targets, I am less concerned here than I might otherwise be I think...|